29th September 2008
Cancer Research UK and Astex Therapeutics Join Forces to Develop New Anti-Cancer Treatment
31st July 2008
CRT Licenses Colorectal Cancer Risk Technology
9th July 2008
ValiRx Acquires Global Rights to Novel Compound Targeted at Prostate Cancer
28th May 2008
Cancer Research UK Creates 'Crack Teams' to Solve Cancer's Greatest Mysteries
19th May 2008
Cancer Research Uk and AstraZeneca Announce Innovative Deal for Promising Anti-Cancer Compound
15th May 2008
CRT Opens Drug Discovery Laboratory in Cambridge
17th January 2008
CRT Licenses Antibody Technology to Glycart
|